Celldex Therapeutics, Inc. · NASDAQ:CLDX

FMR LLC reported a 10.70% stake in Celldex Therapeutics, Inc. (Schedule 13G/A)

Event Sep 30, 2026 · Filed Oct 7, 2026

FMR LLC reported a 10.70% stake in Celldex Therapeutics, Inc., 8,411,905 shares, as a passive investor on Sep 30, 2026. Filed Oct 7, 2026 (Schedule 13G/A).

Stake
10.70%
Shares
8,411,905
Intent
Passive
What changed
Stake changed
Filed together
2 holders

The filing in full

HolderStakeShares
FMR LLC10.70%8,411,905
Abigail P. Johnson10.70%8,411,905

Source

View original at SEC

Related